It's been a long time coming for both natural gas and solar as viable sources of energy in the United States. Both have been struggling with a lack of consumer and industrial buy-in, but both could be right around the corner. Is either one standing out at the moment?
The debate is on
In the following video, Motley Fool analysts Joel South and Taylor Muckerman each weigh in on how natural gas and solar have been performing lately and which companies are taking the lead. Both options have made progress recently, with Clean Energy Fuels (NASDAQ: CLNE ) building out its "America's Natural Gas Highway" initiative and SunPower (NASDAQ: SPWR ) producing more efficient solar panels.
Has Clean Energy Fuels solved the "chicken-or-the-egg" debate?
The movement toward alternative energy is gaining momentum. One potential opportunity in this field is Clean Energy Fuels, which focuses its natural gas efforts primarily on trucking and fleets. It's poised to make a big impact on an essential industry. Learn everything you need to know about Clean Energy Fuels in The Motley Fool's premium research report on the company. Just click here now to claim your copy today.
Top 5 Supermarket Stocks To Watch Right Now: Autoliv Inc (ALV)
Autoliv, Inc. (Autoliv) is a holding company. Autoliv is the supplier of automotive safety systems, with a range of product offerings, including modules and components for passenger and driver-side airbags, side-impact airbag protection systems, seatbelts, steering wheels, safety electronics, whiplash protection systems and child seats, as well as night vision systems, radar and other active safety systems. Autoliv has two main operating segments: airbags/seatbelt (including restraint electronics) products and active safety electronics products. In March 2010, the Company acquired Visteon Corporation's radar system business. In April 2010, the Company acquired Delphi's Occupant Protection Systems (OPS) operations in Korea and China. In addition, in April 2010, Autoliv Inc.'s Automotive Holding AS increased its stake in Norma AS from 51% to 93.74%. Additionally, Skandinaviska Enskilda Banken AB and ING Luxembourg SA sold their 6.67% and 10% stake, respectively, held in Norma AS. In October 2010, the Company acquired 51% interest in Bejing Delpi Automotive Safety Products. In November 2011, the Company acquired the airbag cushion cut&sew assets from Milliken. In June 2012, the Company sold its subsidiary Autoliv Mekan AB to Verktygs Allians i Hassleholm AB.
Autoliv has approximately 80 wholly or partially owned or leased production facilities located in 28 countries, consisting of both component factories and assembly factories. The Company�� component factories manufacture inflators, initiators, textile cushions, webbing materials, electronics, pressed steel parts, springs and overmoulded steel parts used in seatbelt and airbag assembly, seat subsystems, steering wheels and its active safety and night vision systems, and its other safety electronic systems. During the year ended December 31, 2010, Autoliv�� revenues were approximately 67% of airbags and associated products and approximately 33% of seatbelts and associated products. The Company�� markets are in Europe, North A! merica, Asia-Pacific and Japan. Its customers include the car manufacturers.
During 2010, the products manufactured by Autoliv�� consolidated subsidiaries consisted of approximately 121 million complete seatbelt systems (of which approximately 49 million were fitted with pretensioners), approximately 57 million side-impact airbags (including curtain airbags), approximately 28 million frontal airbag modules, approximately 12 million steering wheels, approximately 11 million electronic units (airbag control), approximately 0.4 million active safety systems and 0.1 million night vision systems. Autoliv owns two principal subsidiaries, AAB and Autoliv ASP, Inc. (ASP). Its AAB and ASP are developers, manufacturers and suppliers to the automotive industry of automotive safety systems. AAB and ASP�� products include seatbelts, frontal and side-impact airbags, steering wheels and seat sub-systems, as well as components for such systems.
Advisors' Opinion:- [By Sarah Jones]
Allianz (ALV) gained 3.6 percent to 120.70 euros after reporting a 24 percent rise in first-quarter profit to about 1.7 billion euros after results improved at all of its businesses. Operating profit of 2.8 billion euros also topped analysts��estimates.
- [By Monica Gerson]
Autoliv (NYSE: ALV) is projected to report its Q3 earnings at $1.34 per share on revenue of $2.06 billion.
Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets
Hot Clean Energy Companies To Watch For 2014: Destination XL Group Inc (DXLG)
Destination XL Group, Inc., formerly Casual Male Retail Group, Inc., incorporated in 1976, is a specialty retailer of big and tall men�� apparel with retail operations in the United States and London, England and direct businesses throughout the United States, Canada and Europe. Its direct business includes several catalogs and e-commerce sites, which supports its brands and product extensions. As of January 28, 2012, it operated 360 Casual MaleXL retail stores, 60 Casual MaleXL outlet stores, 16 DestinationXL stores and 14 Rochester Clothing stores. During the third quarter of fiscal 2011, the Company launched its new DestinationXL e-commerce site which, similar to its DXL store concept, brings all of its existing websites together, making it easier for its customer to shop the full array of product selection that it have to offer from all of its brands with the ease of one shopping cart. Full product assortments from Casual MaleXL, Rochester Clothing, ShoesXL and LivingXL can be found at www.destinationxl.com. In addition to its e-commerce and catalog businesses, it operated 7 international Web stores serving twenty-six European countries during fiscal 2011.
Casual MaleXL Outlet
The Company�� 60 Casual MaleXL outlet stores, with their supporting direct business, B&T Factory Direct, generates approximately 12% of the Company's business. It offers a private-label program, specifically for its Casual MaleXL outlet stores and its B&T Factory Direct businesses, which is similar to its lifestyle private label lines found in its full-price retail stores but made at lower costs and sold at lower price points for its value-oriented customers. It carries Canyon Ridge, which is similar in style to its Harbor Bay product line, 555 Turnpike, which is targeted towards its younger customers, and Fuse, a contemporary line similar in style to its Synrgy product line Traveler Technology is a traditional line similar to its Gold Series.
Casual MaleXL Retail
Th! e Casual Male business offers a selection of sportswear, dress clothing, footwear and accessories for the big and tall customer at moderate prices. Its full-price Casual Male merchandise is sold through its 360 Casual MaleXL retail stores, Casual MaleXL catalogs and e-commerce site. The majority of the Casual Male merchandise is basic or fashion-neutral items, such as jeans, casual slacks, tee-shirts, polo shirts, dress shirts and suit separates. Casual Male�� clothing has features specifically designed for its customer, such as waist-relaxer pants, stretch belts, zipper ties, wide band socks, neck-relaxer shirts and clothing with comfort-stretch technology and reinforced stress points. In addition to its many private label lines, it carry several well-known brands of merchandise including: Polo Ralph Lauren, Nautica, Geoffrey Beene, Nautica Jeans Co., Levi��, Dockers, Calvin Klein, Reebok and
Rochester Clothing
At January 28, 2012, it operated 14 Rochester Clothing stores, located in major cities throughout the United States and one store in London, EnglandAn important element to the Company's business is its high-end, luxury fashion apparel offered by Rochester Clothing. Its Rochester Clothing stores carry a selection of apparel, at higher price points, from branded manufacturers, such as Polo Ralph Lauren, Robert Graham, Lacoste, Facconable, DKNY, Calvin Klein, Michael Kors, Brioni, Cutter and Buck, Tommy Bahama, Tommy Hilfilger, Thomas Dean, Paul & Shark and others. The Rochester customer is able to find a range of apparel from traditional and modern sportswear to suits and accessories.
B&T Factory Direct
The Company�� B&T Factory Direct Web store enhances its existing Casual MaleXL outlet stores. The merchandise offered in its B&T Factory Direct catalogs and on its Website is a selection but similar to the merchandise that can be found in its Casual MaleXL outlet stores. In addition, B&T Factory Direct often features a special clearance o! pportunit! ies of product and provides opportunities of product obtained from Casual MaleXL and Rochester Clothing, offering the B&T Factory Direct customer the ability to purchase branded product.
LivingXL
The LivingXL business, which includes its LivingXL Web store and catalogs, specializes in the selling of selected products. The types of products sold on its Website and in its catalogs for both men and women and include chairs, outdoor accessories, travel accessories, bed and bath and fitness equipment.
ShoesXL
Its ShoesXL Web store carries a line of men�� footwear in extended sizes, offering customers a range of footwear. The assortment on ShoesXL is a reflection of its apparel, with an assortment from moderate to luxury and from casual to formal. ShoesXL has a more than 500 styles of shoes, ranging in sizes from 10M to 18M and widths up to 5E. It carries a number of designer brands including Cole Haan, Allen Edmonds, Timberland, Calvin Klein, Lacoste and Bruno Magli. In addition, it has added the expanded shoe assortments within its existing Casual MaleXL and Rochester Clothing catalogs.
Destination
From the DestinationXL homepage, the customers can also search across all of its brands without having to specifically shop Casual Male versus Rochester. By searching for a shirt in their size, DestinationXL provides them product selection from all three of its concepts.
The Company offers selected Casual Male merchandise on their websites at www.Sears.com and www.Sears.ca. It operates 7 online stores for both its Casual MaleXL and Rochester Clothing brands that penetrate 26 European countries, including the U.K., Germany, France, Italy, Spain and the Netherlands. It engages GSI Commerce, Inc. (GSI) for the design, development and operations of the seven online stores. Subsequent to year end, it decided to discontinue its international Web stores including terminating its contract with GSI.
The Comp! any compe! tes with Wal-Mart, J.C. Penney Company Inc, Kohl�� and Pinault-Printemps-Redoute, SA.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Destination XL Group (Nasdaq: DXLG ) , whose recent revenue and earnings are plotted below.
Hot Clean Energy Companies To Watch For 2014: Cardica Inc.(CRDC)
Cardica, Inc. engages in the development of an endoscopic microcutter product line for use by thoracic, bariatric, colorectal, and general surgeons primarily in the United States and internationally. Its microcutter product line under development includes Microcutter XPRESS 30, a multi-fire endolinear microcutter device based on the company?s proprietary ?staple-on-a-strip? technology; Microcutter XPRESS 45, a multi-fire endolinear microcutter device with a 45 millimeter staple line; Microcutter XCHANGE 30, a cartridge based microcutter device; Microcutter FLEXCHANGE 30, a cartridge based microcutter device with a flexible shaft to facilitate endoscopic procedures requiring cutting and stapling; and Microcutter XPRESS 60, a cutting and stapling device for the bariatric and thoracic surgery markets. The company also designs, manufactures, and markets automated anastomotic systems for use by cardiac surgeons to perform coronary bypass surgery. It offers C-Port Distal Anas tomosis Systems, such as C-Port xA Anastomosis System to perform an end-to-side distal anastomosis by attaching the end of a bypass graft to a coronary artery downstream of an occlusion or narrowing; C-Port Flex A Anastomosis System to enable automated anastomoses to be performed as part of coronary artery bypass grafting procedures; C-Port X-CHANGE System, a cartridge-based reloadable C-Port system; and PAS-Port Proximal Anastomosis System to perform an end-to-side proximal anastomosis between a saphenous vein and the aorta. In addition, the company licenses its intellectual property in the robotics field in diagnostic or therapeutic medical procedures. Cardica, Inc. sells its products through direct sales force, as well as through independent distributors and manufacturers? representatives. The company was formerly known as Vascular Innovations, Inc. and changed its name to Cardica, Inc. in November 2001. Cardica, Inc. was founded in 1997 and is headquartered in Redwood C ity, California.
Advisors' Opinion:- [By Bryan Murphy]
Neither Acorn Energy Inc. (NASDAQ:ACFN) nor Cardica, Inc. (NASDAQ:CRDC) may look all that compelling with just a passing glance. The longer one examines CRDC and ACFN, however - and really gets a grasp of their underlying stories - the more compelling each one becomes. In fact, newcomers may want to go ahead and put both budding stocks on their watchlists, if not in their portfolios.
Hot Clean Energy Companies To Watch For 2014: Ishares Trust Russell (IWD)
iShares Russell 1000 Value Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the large-capitalization value sector of the United States equity market, as represented by the Russell 1000 Value Index (the Index). The Index is a subset of the Russell 1000 Index. The Index is a capitalization-weighted index and consists of those companies or portion of a company, with lower price-to-book ratios and lower forecasted growth within the Russell 1000 Index. The Index represents approximately 51% of the total market capitalization of the Russell 1000 Index.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to Index. iShares Russell 1000 Value Index Fund's investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By James Brumley]
It’s been especially untrue the last few years. Since this point in the year back in 2003, the iShares Russell 1000 Growth Fund (IWF) has advanced 81%, while the iShares Russell 1000 Value Fund (IWD) has only advanced 67%.
Hot Clean Energy Companies To Watch For 2014: International Game Technology (IGT)
International Game Technology (IGT) designs, manufactures, and markets electronic gaming equipment and systems worldwide. The company offers casino-style slot machines that determine the game play outcome at the machine; wide area progressive jackpot systems with linked machines across various casinos; central determination system machines connected to a central server that determines the game outcome, encompassing video lottery terminals used primarily in government-sponsored applications and electronic or video bingo machines; and amusement with prize games. Its systems products include applications for casino management, customer relationship marketing (CRM), and server-based games and player management. IGT?s casino management solutions comprise integrated modules for machine accounting, patron management, cage and table accounting, ticket-in/ticket-out, bonusing (jackpots and promotions), and table game automation. The company?s CRM solutions feature integrated market ing and business intelligence modules that provide analytical, predictive, and management tools for maximizing casino operational effectiveness; and server-based solutions enable game delivery to slot machines, computers, mobile phones, tablets, and other networked devices. Its gaming markets comprise the United States, Canada, Europe, the Middle East, Africa, Mexico and South/Central America, Asia, Australia, New Zealand, the Pacific, and the United Kingdom. The company was founded in 1980 and is headquartered in Reno, Nevada.
Advisors' Opinion:- [By Johanna Bennett]
This is not the first coupling for Scientific Games. In late 2013, it bagged WMS Industries, a maker of gambling equipment, for $1.42 billion, while Bally acquired fellow casino-device maker SHFL Entertainment for $1.3 billion. And in mid-July, casino-equipment maker International Game Technology (IGT) agreed to be acquired by Italian lottery-operator Gtech in a deal worth $4.7 billion.
- [By Patientbioinvest]
Let�� take a look at his top three buys over the last quarter:
AT&T (T): This is a new holding for the fund. Olstein bought 146,000 shares at prices between $33.1 and $36.45. The current stock price is 33.01, i.e. a 5% to the average high-low price over the period. The stock has been in a bear trend for more than a year but counts Gurus James Barrow (Trades, Portfolio) and Brian Rogers (Trades, Portfolio) as biggest holders. AON (AON): The fund purchased 60,000 shares in the insurance company for a 0.75% impact to the portfolio. The stock is still trading at the upper bound of the high-low price ranges over the past quarter. Aon PLC provides risk management and human capital consulting services, delivering distinctive client value via risk management solutions, including insurance and reinsurance brokerage and workforce productivity solutions. It is also noteworthy that the stock saw a large insider buy of more than $2 million by one of the company�� director 10 days ago. International Game Technology (IGT): IGT is a global gaming company specializing in the design, manufacture and marketing of electronic gaming equipment and systems products. The Olstein fund added 246,000 shares of the company over the last quarter. The current price is at a 20% discount to the average of the price range over the period. It is noteworthy that Guru John Hussman (Trades, Portfolio) also bought 500,000 shares over the same period.
Also check out: Robert Olstein Undervalued Stocks Robert Olstein Top Growth Companies Robert Olstein High Yield stocks, and Stocks that Robert Olstein keeps buying
Currently 3.00/512345Rating: 3.0/5 (2 votes)
- [By John Divine]
International Game Technology (NYSE: IGT ) , which largely lives and dies with the success of the casino industry, saw shares slump 2.5% today. Not only is International Game Technology in the traditional business of offering products like video poker and slot machines, but it's at the forefront of social, mobile, and online gaming, all of which are enormous avenues for growth in the industry going forward. Unfortunately for IGT, its $500 million investment in social gaming company Double Down in 2012 is starting to look like a dud, with Double Down's founders leaving IGT earlier this year, just as the company announced an earnings hit from the two-year-old acquisition.
- [By John Divine]
Lastly, slot machine maker International Game Technology (NYSE: IGT ) slumped 7.3%, due largely to negative analyst sentiment. Unlike AMD and Microsoft, IGT doesn't report quarterly results until next Tuesday, so the comments today were sure to attract the attention of some uneasy investors before official numbers come out. A Janney Capital Markets analyst said that the stock's been driven up to a point where it no longer offers newcomers an attractive entry point. On top of that, IGT is set to start losing market share, will see higher costs, and will be able to buy back less stock in the future, according to the report.�
Hot Clean Energy Companies To Watch For 2014: Intellicell Biosciences Inc (SVFC)
Intellicell Biosciences, Inc., formerly Media Exchange Group, Inc., incorporated on March 8, 1999, is engaged in regenerative medicine company focused on the expanding regenerative medical markets using a process to separate adult autologous vascular cells (AAVC's) from blood vessels in adult adipose (fat) tissue. The Company is also exploring and undertaking, either on its own or in collaboration with a third party, providing a service for the collection, processing and storage of autologous cells for future use. As of December 31, 2011, the Company has developed technologies that allow reproducible separation of stromal vascular fraction (IntelliCell) containing adipose stem cells that can be performed in tissue processing centers and in doctors��offices. On June 3, 2011, the Company completed the acquisition of Intellicell Biosciences, Inc. The Company formed a wholly-owned subsidiary, ICBS Research, Inc.
The Company's process involves the application of ultrasonic cavitation (sound waves) to the extracted adipose tissue, which results in the separation AAVC's from the blood vessels in adult adipose (fat) tissue. This AAVC, or stromal vascular fraction (IntelliCells), are removed from the patient at the point of care, and separated at the point of care under the supervision of its certified technicians following current good manufacturing practices (cGMPs) and current good tissue practices (cGTPs), and the cells are then returned to the medical professionals at the point of care for use a patient's own body (autologous treatment), by way of a same-day clinical procedure for homologous use of these cells.
Intellicell Biosciences, Inc., formerly Media Exchange Group, Inc., incorporated on March 8, 1999, is engaged in regenerative medicine company focused on the expanding regenerative medical markets using a process to separate adult autologous vascular cells (AAVC's) from blood vessels in adult adipose (fat) tissue. The Company is also exploring and undertaking, either on ! its own or in collaboration with a third party, providing a service for the collection, processing and storage of autologous cells for future use. As of December 31, 2011, the Company has developed technologies that allow reproducible separation of stromal vascular fraction (IntelliCell) containing adipose stem cells that can be performed in tissue processing centers and in doctors��offices. On June 3, 2011, the Company completed the acquisition of Intellicell Biosciences, Inc. The Company formed a wholly-owned subsidiary, ICBS Research, Inc.
The Company's process involves the application of ultrasonic cavitation (sound waves) to the extracted adipose tissue, which results in the separation AAVC's from the blood vessels in adult adipose (fat) tissue. This AAVC, or stromal vascular fraction (IntelliCells), are removed from the patient at the point of care, and separated at the point of care under the supervision of its certified technicians following current good manufacturing practices (cGMPs) and current good tissue practices (cGTPs), and the cells are then returned to the medical professionals at the point of care for use a patient's own body (autologous treatment), by way of a same-day clinical procedure for homologous use of these cells.
The Company competes with Cytori Therapeutics, Stem Cell Assurance, Inc., Osiris, Aastrom Biosciences, Aldagen, BioTime, Baxter International, Celgene, Geron, Harvest Technologies, Mesoblast, Regenexx, NeoStem, X-Cell Center, Stem Cells, Athersys, and Tissue Genesis, Life Technologies, Asterand, pacific biosciences of california inc. and AllCells, LLC.
Advisors' Opinion:- [By Bryan Murphy]
Well, though I give myself a C for timing, it looks like I'm going to be able to give myself an A for stock-picking. Back on January 27th I deemed IntelliCell BioSciences, Inc. (OTCMKTS:SVFC) was a compelling buy, and though SVFC was stagnant for a month after that, it looks like the stock's finally getting on its horse. If you didn't get it then, you may want to get in now.
- [By Bryan Murphy]
To say that shares of IntelliCell BioSciences, Inc. (OTCMKTS:SVFC) has been disappointing since 2011 would be an understatement. SVFC has been an outright disaster since 2011, falling from a peak of $19.00 to a low of, well, just a few pennies as of late last year. In fact, there are those who are understandably wondering how the company is still alive, only producing about a half a million dollars in revenue in 2012, and then dialing that figure back down to nothing for the last few quarters. Yet, there's just something about a company that refuses to go away.... something compelling now.
Hot Clean Energy Companies To Watch For 2014: Johnson & Johnson(JNJ)
Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment provides products used in baby care, skin care, oral care, wound care, and women?s health care fields, as well as nutritional, over-the-counter pharmaceutical products, and wellness and prevention platforms under the brands of JOHNSON?S, AVEENO, CLEAN & CLEAR, JOHNSON?S Adult, NEUTROGENA, RoC, LUBRIDERM, DABAO, LISTERINE, REACH, BAND-AID, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC. The Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, and virology. Its principal products include REMICADE for the treatment of immune me diated inflammatory diseases; STELARA for the treatment of moderate to severe plaque psoriasis; SIMPONI, a treatment for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; VELCADE for the treatment of multiple myeloma; PREZISTA and INTELENCE for treating HIV/AIDS patients; NUCYNTA for moderate to severe acute pain; INVEGA SUSTENNAtm for the acute and maintenance treatment of schizophrenia in adults; RISPERDAL CONSTA for the management of bipolar I disorder and schizophrenia; and PROCRIT to stimulate red blood cell production. The Medical Devices and Diagnostics segment primarily offers circulatory disease management products; orthopaedic joint reconstruction, spinal care, and sports medicine products; surgical care, aesthetics, and women?s health products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. The company was founded in 1886 and is based in Ne w Brunswick, New Jersey.
Advisors' Opinion:- [By John Divine]
As for outperformers, only five Dow stocks ended in the black on Monday, with Johnson & Johnson (NYSE: JNJ ) leading the way on 1.7% gains. There wasn't anything in particular that made the health-care giant immune to today's losses, but it sure doesn't hurt that the company is one of the largest, most established, and well-known companies in the world. It's worth nearly $240 billion, and pays out a 3.2% dividend to investors, so it's a good option for investors seeking safety in equities.
- [By Dan Carroll and Max Macaluso, Ph.D.]
We're into the heart of earnings season, and several of the medical device industry's biggest players have already reported quarterly results. Johnson & Johnson (NYSE: JNJ ) led off among the biggest players, with fellow diversified health care firm Abbott Labs (NYSE: ABT ) and more concentrated company St. Jude Medical (NYSE: STJ ) following suit last week.
- [By Brian Orelli]
The ertugliflozin-Januvia combination could be a big blow to Johnson & Johnson's (NYSE: JNJ ) recently approved Invokana. The drug is an SGLT-2 inhibitor, the same class as ertugliflozin. Invokana will have a couple of years' head start, but it'll have a hard time competing against a ertugliflozin-Januvia combination pill for patients that need to take both drugs. Doctors and patients both prefer fewer pills, so assuming that the efficacy and safety are similar, the combination product should win out.
- [By Dividends4Life]
There are a number of ways to invest successfully. I have friends who are very successful value investors. Most of their returns are earned through capital appreciation. They spend a great deal of time pouring through 10-Ks and 10-Qs of companies off the beaten path. The potential returns are high, but so is the effort put in their craft. At the other extreme there are successful traders. They look at their charts to determine entry and exit points for the day's transactions. Little to no time is spent analyzing the underlying fundamentals of the company since it likely will only be held for a very short period of time. I would put investors in dividend growth stocks somewhere between these two, but much closer to the pure value investor. Like the value investors, our time-frame is long term. Although we carefully research potential companies, our emphasis leans more toward fundamental metrics needed to sustain annual dividend growth, with less emphasis on current value. There are successful investors in each of the above groups, and they share a common trait. This trait is found in most all successful people ���t is their secret to success. Fortunately, this trait can be learned and mastered. The secret to successful investing is... discipline. A person that moves from one investment strategy to another lacks the discipline to be successful. Very few people are born with the raw intellect that allows them to just pick winning stocks out of the air. For the rest of us, we have to rely on our discipline to do what's necessary to identify stocks that will provide us with our best opportunity to succeed, and we have to remain focused on quality over the long-term. Our portfolios include stocks like:Emerson Electric Co. (EMR) | Yield: 2.5% Emerson Electric Co. designs and supplies product technology and delivers engineering services and solutions to a wide range of industrial, commercial and consumer markets around the world. The company has paid a cash dividend t
No comments:
Post a Comment